Pulmonary Carcinoids: Diagnostic and Therapeutic Approach

Area of Science:

• Oncology
• Pulmonology
• Pathology

Background:

• Pulmonary carcinoids (PCs) are rare neuroendocrine tumors, accounting for 1-2% of all invasive lung malignancies.
• They are classified as typical carcinoid (TC) or atypical carcinoid (AC) and originate from the pulmonary diffuse neuroendocrine system.

Purpose of the Study:

• To provide an overview of current diagnostic and therapeutic approaches for pulmonary carcinoids.
• To highlight the management strategies based on tumor stage and characteristics.

Main Methods:

• Review of current literature on pulmonary carcinoids.
• Discussion of diagnostic modalities including chest X-ray and CT scans.
• Analysis of treatment options, emphasizing surgical resection and medical management.

Main Results:

• Over 40% of PCs are incidentally detected on chest X-rays; CT is the diagnostic gold standard.
• Surgical resection is the primary treatment for localized disease, aiming for complete removal with lung preservation.
• Advanced PCs often require medical management for symptom control and tumor progression limitation.

Conclusions:

• Pulmonary carcinoids require a multidisciplinary approach for optimal management.
• Early diagnosis and surgical intervention improve outcomes for typical and atypical carcinoids.
• Ongoing research is crucial for refining treatment strategies for advanced pulmonary neuroendocrine tumors.